US$ 25.69
glp-1 news today october 20 2025 Drugs: A New Clue in Inflammation, Blood Cancer, and Cancer Risk Dr. Blum and our patient
Description
Kristin Baier, Calibrate's vice president of clinical development, in an interview
Progress and challenges in anti-obesity pharmacotherapy

Mol Nutr Food Res 2022;66:e2100897

Safety first: when to call your clinician GLP-1 medications are generally well tolerated, but like with any treatment, side effects can occur
